Source: News Bites
Published 4:08 PM, 9 Aug 2010
Source: News Bites
http://www.businessspectator.com.au/bs.nsf/Article/Virax-awaiting-HIV-vaccine-trial-results-869CS?opendocument&src=rss
Virax Holdings Ltd is awaiting results from the phase IIa cinical trial in South Africa for its HIV therapeutic vaccine, VIR201.
All immunological laboratory analyses have been completed and data input into the clinical trial database.
Results are expected in 1-2 weeks.
VIR201 treats HIV-infected individuals by lowering viral load. Current HIV treatments typically use a combination of antiretroviral therapies which often have unwanted side effects.
- Forums
- ASX - By Stock
- VHL
- virax awaiting hiv vaccine trial results
VHL
vitasora health limited
Add to My Watchlist
0.00%
!
2.6¢

virax awaiting hiv vaccine trial results
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
2.6¢ |
Change
0.000(0.00%) |
Mkt cap ! $44.68M |
Open | High | Low | Value | Volume |
2.5¢ | 2.6¢ | 2.5¢ | $156 | 6.012K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
2 | 167796 | 2.5¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
2.7¢ | 146386 | 2 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
2 | 167796 | 0.025 |
8 | 1052433 | 0.024 |
5 | 1074000 | 0.023 |
4 | 361000 | 0.022 |
6 | 483423 | 0.021 |
Price($) | Vol. | No. |
---|---|---|
0.027 | 146386 | 2 |
0.028 | 497220 | 3 |
0.029 | 510563 | 2 |
0.030 | 984470 | 6 |
0.031 | 1222858 | 4 |
Last trade - 15.03pm 12/08/2025 (20 minute delay) ? |
Featured News
VHL (ASX) Chart |